Table 2.
Significant overrepresentation in VAT of validated targets of transcription factors (TF), TF complexes or families in HFoleic vs. Reference group comparison.
| Name | Hits (n) | Adjusted p-Value | |
|---|---|---|---|
| Transcription factors | SP1 | 104 | <0.001 |
| SP3 | 45 | <0.001 | |
| SPI1 | 27 | <0.001 | |
| CEBPB | 31 | <0.001 | |
| IRF1 | 16 | <0.01 | |
| IRF8 | 12 | <0.01 | |
| HIF1A | 16 | <0.01 | |
| STAT1 | 15 | <0.01 | |
| YY1 | 18 | <0.01 | |
| USF1 | 15 | <0.01 | |
| CEBPA | 17 | <0.01 | |
| EGR1 | 15 | <0.01 | |
| RELA | 15 | <0.05 | |
| ETS1 | 12 | <0.05 | |
| POU2F1 | 14 | <0.05 | |
| STAT3 | 13 | <0.05 | |
| NFYA | 12 | <0.05 | |
| Transcription factor complexes | AP-1 | 24 | <0.001 |
| NF-kappaB | 14 | <0.05 | |
| PPARgamma:RXR-alpha | 8 | <0.05 | |
| RelA-p65:p50 | 9 | <0.05 | |
| USF2:usf1 | 8 | <0.05 | |
| Transcription factor families | NF-1 | 14 | <0.05 |